Dennis Hulme
Stock Analyst at Taylor Collison
(0.62)
# 4,219
Out of 5,032 analysts
13
Total ratings
25%
Success rate
-11.7%
Average return
Main Sectors:
Stocks Rated by Dennis Hulme
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: IMR Imricor Medical Systems, Inc. | Reiterated: Buy | $3.45 → $3.40 | $1.41 | +141.99% | 4 | Jul 28, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $19.61 | $15.94 | n/a | 1 | Aug 26, 2024 | |
| ASX: GSS Genetic Signatures Limited | Reiterated: Buy | $2.19 → $2.21 | $0.08 | n/a | 3 | May 17, 2024 | |
| ASX: PER Percheron Therapeutics Limited | Reiterated: Buy | $0.15 | $0.00 | n/a | 3 | Apr 4, 2024 | |
| ASX: SNT Syntara Limited | Reiterated: Buy | n/a | $0.021 | n/a | 1 | Jun 21, 2023 | |
| ASX: IMM Immutep Limited | Reiterated: Buy | n/a | $0.03 | n/a | 1 | Jun 10, 2022 |
Imricor Medical Systems, Inc.
Jul 28, 2026
Reiterated: Buy
Price Target: $3.45 → $3.40
Current: $1.41
Upside: +141.99%
Telix Pharmaceuticals Limited
Aug 26, 2024
Reiterated: Buy
Price Target: $19.61
Current: $15.94
Upside: n/a
Genetic Signatures Limited
May 17, 2024
Reiterated: Buy
Price Target: $2.19 → $2.21
Current: $0.08
Upside: n/a
Percheron Therapeutics Limited
Apr 4, 2024
Reiterated: Buy
Price Target: $0.15
Current: $0.00
Upside: n/a
Syntara Limited
Jun 21, 2023
Reiterated: Buy
Price Target: n/a
Current: $0.021
Upside: n/a
Immutep Limited
Jun 10, 2022
Reiterated: Buy
Price Target: n/a
Current: $0.03
Upside: n/a